6th International Conference on Cancer Research and Treatment

Precision Medicine and Personalized Oncology are redefining cancer care by tailoring prevention, diagnosis, and treatment to the unique biological profile of each patient. This session explores how advances in genomics, molecular diagnostics, and biomarker-driven strategies are enabling more accurate treatment selection and improved therapeutic outcomes across diverse cancer types. Participants will gain insights into the role of individualized care in addressing tumor heterogeneity, minimizing treatment-related toxicity, and enhancing patient-centered oncology practice.

Genomic & Molecular Profiling in Cancer Care

Advances in tumor genomics and molecular diagnostics are enabling precise risk stratification and treatment planning. This subtopic highlights the role of multi-omics profiling in understanding tumor behavior and guiding personalized therapeutic decisions. Emphasis is placed on improving prognostic accuracy across cancer types.

Biomarker-Driven Targeted Therapies

This subtopic focuses on the identification and clinical application of predictive and prognostic biomarkers. It explores how biomarker-guided therapies optimize treatment efficacy while minimizing toxicity. Discussions highlight precision-driven approaches to individualized cancer care.

Pharmacogenomics & Individualized Drug Response

Explore how genetic variations influence drug metabolism, efficacy, and safety in oncology. This subtopic emphasizes personalized dosing strategies and treatment selection to reduce adverse reactions. It supports the development of safer and more effective cancer therapies.

Precision Immuno-Oncology

This subtopic covers personalized immunotherapeutic strategies, including immune checkpoint inhibitors, CAR-T cell therapy, and neoantigen-based treatments. It highlights immune profiling approaches used to tailor therapies to individual patients. Focus is placed on enhancing response rates and long-term outcomes.

AI, Big Data & Digital Precision Oncology

Examine the integration of artificial intelligence and big data in precision cancer care. This subtopic explores predictive modeling, clinical decision support, and data-driven treatment planning. Emphasis is placed on improving diagnostic accuracy and personalized treatment strategies.

Liquid Biopsy & Non-Invasive Precision Diagnostics

This subtopic highlights the emerging role of liquid biopsy technologies in cancer management. It focuses on circulating tumor DNA and other biomarkers for early detection and real-time treatment monitoring. Discussions address their impact on disease surveillance and therapy optimization.